In hepatocellular carcinoma (HCC), suppression of CES1 leads to a significant reduction in lipid signaling molecules of PPARα/γ, with a notable downregulation of the PPARα/γ target gene SCD, which is associated with tumor metastasis, recurrence, and chemoresistance. Here, CES1 is linked to neoplasm.